Xiangli Cui

2.4k total citations
82 papers, 1.8k citations indexed

About

Xiangli Cui is a scholar working on Molecular Biology, Cardiology and Cardiovascular Medicine and Epidemiology. According to data from OpenAlex, Xiangli Cui has authored 82 papers receiving a total of 1.8k indexed citations (citations by other indexed papers that have themselves been cited), including 34 papers in Molecular Biology, 15 papers in Cardiology and Cardiovascular Medicine and 12 papers in Epidemiology. Recurrent topics in Xiangli Cui's work include Venous Thromboembolism Diagnosis and Management (10 papers), Glioma Diagnosis and Treatment (9 papers) and Atrial Fibrillation Management and Outcomes (7 papers). Xiangli Cui is often cited by papers focused on Venous Thromboembolism Diagnosis and Management (10 papers), Glioma Diagnosis and Treatment (9 papers) and Atrial Fibrillation Management and Outcomes (7 papers). Xiangli Cui collaborates with scholars based in China, United States and Canada. Xiangli Cui's co-authors include Lorne J. Hofseth, Alexander A. Chumanevich, Deepak Poudyal, Anne B. Hofseth, Prakash Nagarkatti, Jin Yu, Lihong Liu, Mitzi Nagarkatti, Zhikang Ye and Udai P. Singh and has published in prestigious journals such as SHILAP Revista de lepidopterología, PLoS ONE and Cancer Research.

In The Last Decade

Xiangli Cui

80 papers receiving 1.8k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Xiangli Cui China 26 645 278 230 190 178 82 1.8k
Kaoruko Iida Japan 27 800 1.2× 416 1.5× 166 0.7× 229 1.2× 238 1.3× 58 2.3k
Guoying Zhang China 25 910 1.4× 186 0.7× 517 2.2× 259 1.4× 164 0.9× 87 2.2k
Feng Huang China 22 758 1.2× 192 0.7× 298 1.3× 107 0.6× 356 2.0× 123 1.8k
Lei Gao China 21 647 1.0× 168 0.6× 269 1.2× 176 0.9× 127 0.7× 123 1.5k
Ya‐Long Feng China 23 1.5k 2.3× 259 0.9× 229 1.0× 221 1.2× 177 1.0× 33 3.0k
Xinling Liang China 26 808 1.3× 398 1.4× 144 0.6× 114 0.6× 217 1.2× 159 2.5k
Manal S. Fawzy Egypt 27 880 1.4× 205 0.7× 701 3.0× 214 1.1× 107 0.6× 177 2.4k
Xizhen Xu China 28 608 0.9× 225 0.8× 190 0.8× 192 1.0× 241 1.4× 62 2.3k
Michel Vaubourdolle France 23 663 1.0× 314 1.1× 185 0.8× 145 0.8× 81 0.5× 97 2.0k
Sandra Rayego‐Mateos Spain 31 1.3k 2.1× 262 0.9× 252 1.1× 191 1.0× 207 1.2× 72 3.1k

Countries citing papers authored by Xiangli Cui

Since Specialization
Citations

This map shows the geographic impact of Xiangli Cui's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Xiangli Cui with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Xiangli Cui more than expected).

Fields of papers citing papers by Xiangli Cui

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Xiangli Cui. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Xiangli Cui. The network helps show where Xiangli Cui may publish in the future.

Co-authorship network of co-authors of Xiangli Cui

This figure shows the co-authorship network connecting the top 25 collaborators of Xiangli Cui. A scholar is included among the top collaborators of Xiangli Cui based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Xiangli Cui. Xiangli Cui is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Yan, Yan, Donghua Liu, Jing Tang, et al.. (2024). Risk of transplant rejection associated with ICIs prior to liver transplantation in HCC: A multicenter retrospective study. International Immunopharmacology. 143(Pt 2). 113400–113400. 5 indexed citations
2.
3.
Zhao, Ying, et al.. (2023). Pharmacokinetics and Dosing Regimens of Direct Oral Anticoagulants in Morbidly Obese Patients: An Updated Literature Review. Clinical and Applied Thrombosis/Hemostasis. 29. 2995335142–2995335142. 11 indexed citations
4.
Li, Dandan, et al.. (2023). Evidence of potential pro‐haemorrhagic drug interactions between CYP3A4 inhibitors and direct oral anticoagulants: Analysis of the FAERS database. British Journal of Clinical Pharmacology. 89(8). 2423–2429. 2 indexed citations
5.
Zhang, Zhiqi, Ying Zhao, Dandan Li, et al.. (2023). Safety, efficacy and prognosis of anticoagulant therapy for portal vein thrombosis in cirrhosis: a retrospective cohort study. Thrombosis Journal. 21(1). 13–13. 12 indexed citations
6.
7.
Guo, Mingxing, et al.. (2022). Coagulation dysfunction events associated with tigecycline: a real-world study from FDA adverse event reporting system (FAERS) database. Thrombosis Journal. 20(1). 12–12. 20 indexed citations
8.
Guo, Mingxing, et al.. (2021). Evaluation of rivaroxaban-, apixaban- and dabigatran-associated hemorrhagic events using the FDA-Adverse event reporting system (FAERS) database. International Journal of Clinical Pharmacy. 43(6). 1508–1515. 5 indexed citations
9.
10.
Yang, Hui, et al.. (2017). Effectiveness of Pharmacist-led Anticoagulation Management on Clinical Outcomes: A Systematic Review and Meta-Analysis. Journal of Pharmacy & Pharmaceutical Sciences. 20(1). 378–378. 36 indexed citations
11.
12.
Witalison, Erin E., Xiangli Cui, Anne B. Hofseth, et al.. (2015). Inhibiting Protein Arginine Deiminases Has Antioxidant Consequences. Journal of Pharmacology and Experimental Therapeutics. 353(1). 64–70. 12 indexed citations
13.
Poudyal, Deepak, Xiangli Cui, Phuong Mai Le, et al.. (2013). A Key Role of microRNA-29b for the Suppression of Colon Cancer Cell Migration by American Ginseng. PLoS ONE. 8(10). e75034–e75034. 51 indexed citations
14.
Zhang, Li, Qinghua Liu, Ruiling Xu, et al.. (2013). Zacopride selectively activates the Kir2.1 channel via a PKA signaling pathway in rat cardiomyocytes. Science China Life Sciences. 56(9). 788–796. 17 indexed citations
15.
Jiang, Haihui, Xiaohui Ren, Wei Zhang, et al.. (2012). A new prognostic scoring scale for patients with primary WHO grade III gliomas based on molecular predictors. Journal of Neuro-Oncology. 111(3). 367–375. 14 indexed citations
16.
Yu, Jin, Anne B. Hofseth, Xiangli Cui, et al.. (2010). American Ginseng Suppresses Colitis through p53-Mediated Apoptosis of Inflammatory Cells. Cancer Prevention Research. 3(3). 339–347. 55 indexed citations
17.
Cui, Xiangli, Jin Yu, Anne B. Hofseth, et al.. (2010). Resveratrol Suppresses Colitis and Colon Cancer Associated with Colitis. Cancer Prevention Research. 3(4). 549–559. 179 indexed citations
18.
Chumanevich, Alexander A., Deepak Poudyal, Xiangli Cui, et al.. (2010). Suppression of colitis-driven colon cancer in mice by a novel small molecule inhibitor of sphingosine kinase. Carcinogenesis. 31(10). 1787–1793. 83 indexed citations
19.
Hristov, Kiril L., et al.. (2008). Stimulation of β3-adrenoceptors relaxes rat urinary bladder smooth muscle via activation of the large-conductance Ca2+-activated K+ channels. American Journal of Physiology-Cell Physiology. 295(5). C1344–C1353. 72 indexed citations
20.
Yu, Jin, Venkata Subbaiah Kotakadi, Ying Lei, et al.. (2008). American ginseng suppresses inflammation and DNA damage associated with mouse colitis. Carcinogenesis. 29(12). 2351–2359. 68 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Kaoruko Iida Breakdown of academic impact, for papers by Guoying Zhang Breakdown of academic impact, for papers by Feng Huang Breakdown of academic impact, for papers by Lei Gao Breakdown of academic impact, for papers by Ya‐Long Feng Breakdown of academic impact, for papers by Xinling Liang Breakdown of academic impact, for papers by Manal S. Fawzy Breakdown of academic impact, for papers by Xizhen Xu Breakdown of academic impact, for papers by Michel Vaubourdolle Breakdown of academic impact, for papers by Sandra Rayego‐Mateos
Rankless by CCL
2026